Editor's Note: Abhimanyu Mahajan, MD, MHS, Assistant Professor, Department of Neurological Sciences, Rush University, Chicago, Illinois, served as co-author on this article.
Before I started medical school, I assumed that medical practice dealt in absolutes.
COMMENTARY
Hope, Hype, and the Problem With New Drug Development
Caroline Olvera, MD
DisclosuresMay 06, 2022
Editor's Note: Abhimanyu Mahajan, MD, MHS, Assistant Professor, Department of Neurological Sciences, Rush University, Chicago, Illinois, served as co-author on this article.
Before I started medical school, I assumed that medical practice dealt in absolutes.
Join the Top Medical Resource for Physicians Today. Free Membership!
Credits:
Lead image: Neacsu Razvan Chirnoaga/Dreamstime
Medscape Neurology © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Hope, Hype, and the Problem With New Drug Development - Medscape - May 06, 2022.
Tables
Authors and Disclosures
Authors and Disclosures
Author
Caroline Olvera, MD
Movement Disorders Fellow, Department of Neurology, Rush University Medical Center, Chicago, Illinois
Disclosure: Caroline Olvera, MD, has disclosed no relevant financial relationships.